#Syndicate dispensary

[kilopcor]

Syndicate dispensary

SYNDICATE DISPENSARY LICENSE

SYNDICATE DISPENSARY LICENSE

El Paso dispensaries can only provide marijuana legally if the license is valid. Knox Medical is an Austin Low-THC Medical Marijuana Dispensary Coming soon, Knox Medical will launch their low-THC medical marijuana dispensary in the heart of Austin, Texas and provide epileptic patients with alternative, cannabis-based relief. Edinburg is home to 1 dispensaries, and many people often also shop for bongs, vaporizers, and dab rigs. We have all of the weed dispensaries in the U.S. Since 2001, we are committed to delivering quality marijuana to our customers worldwide, again, we now have edibles discreet shipping Texas and many more. Our favorite Edinburg dispensary is Earthonomics Hemp Flower and CBD. Cultivate was one of the first two medical sales dispensaries in Massachusetts - and the eastern half of the country - to begin shop the drug to all adults over 21 years old on Nov. While Durango is a longer drive into Colorado, it's also a place you'll want to hang out … See if you qualify today! Cannabis Dispensaries. Closest Texas County Dispensaries Marijuana Dispensaries, Lounges, Flower, Concentrates, CBD and THC Edibles near Wichita Falls, Texas 76308 Find weed near you easily with our maps and guide. Read reviews and menus of dispensaries in your area. In a cannabis dispensary, consumers can often find flowers, concentrates, prefilled vape cartridges, edibles, hemp oil, CBD, and more cannabis products. Find reviews and menus from the best recreational & medical marijuana dispensaries in Fort Worth, TX. Midland dispensaries can only provide marijuana legally if the license is valid. The option to home grow up to six marijuana plants is available as well. Explore other popular stores near you from over 7 million businesses with over 142 million reviews and opinions from Yelpers. Find local marijuana dispensaries, deliveries, and doctors where you can buy marijuana, seeds, clones, get a medical marijuana card, and more! Without implicating myself any further, the best I can do is tell you about the dispensaries closest to north Texas. "This is the new cash crop," said Lindsey Bartlett, a "bud-tender" at downtown Denver dispensary MMJ America, one of more than 100 medical marijuana dispensaries in Denver that applied to … The third way is the easiest and that is to find a legal marijuana business with a valid license on Mama's Ganja. For a list of dispensaries in Houston, visit this map for more information. The only thing we can buy in a dispensary is CBD oil, and it has to contain less than 0.5% of THC. What’s more, keep in mind that dispensaries can’t sell marijuana flowers. Penalties for growing weed are pretty similar to those for possession. Texas County MedCard patients and their registered caregivers can buy medical marijuana products at open dispensaries. Find the best Recreational Marijuana Dispensaries near you on Yelp - see all Recreational Marijuana Dispensaries open now. In 2014 the first recreational dispensary, 3D Cannabis opened it’s doors in Colorado. Marshall dispensaries in 49068 can be found in this marijuana dispensary directory along with our trusted list of medical and recreational legal weed dispensaries, THC and CBD suppliers, doctor recommendation and evaluation services, clinics and medical marijuana dispensaries in the City of Marshall in Calhoun County, Michigan. Texas' first cannabis dispensary opened Thursday, but it looks nothing like the ones in states where recreational marijuana is legal. Recreational dispensaries in El Paso will not be around as we wait and see if Texas legalizes recreational weed for adult use. If you rely on or make use of any of the information on this website to make any financial decision, then you do so entirely at your own risk and shall not hold the creator, publisher, or website owner accountable for your misuse of the content on Beta Syndicate and or potential for your financial loss or losses after visiting or our branded publications off site.However, no marijuana products may be brought in or out of Texas. We (Beta Syndicate and its Agents) do not make any representations or warranty on the accuracy, correctness or completeness of the information provided on this page or any page found on or our Branded Outlets. All Publications on Beta Syndicate or Beta Syndicate Branded Publications are presented and intended as and only as and for informational, advertorial, or entertainment purposes only, and should not be understood or misconstrued as investment advice.Īny opinion that may be provided on this page, or any page on, or Beta Syndicate's Branded Publications, Textual or Video, Audio, or any graphic or media related to Beta Syndicate, does not constitute as a recommendation by Beta Syndicate or by its agents. DISCLAIMER: Absolutely nothing published on represents or constitutes as financial or legal advice.

[desinvoltfortune]

Cannabis stores in Toronto

Canna Cabana

I'm not a smoker but rather I really do address one in the talkies.....

Simply kidding yet I came here with/for my Better half. This spot is so easygoing. A greatly improved feel then the Honey Pot on Sovereign and College.

You can't smell the examples like the Honey pot yet the staff is still genuinely proficient and agreeable.

When you stroll in you are in an open room with tables of the item and simple to understand names so you understand what you're snatching.

We will be returning again soon, for research....hahah

Tokyo Smoke

Strengths

Tokyo Smoke is for the refined and inquisitive marijuana wayfarer, the individuals who embrace great quality items and elective perspectives. We give visitors a top notch, vivid and instructive experience.

Nova Pot

I love this store.

Individuals that work here are awesome. I've had the option to acquire such a lot of information from them that I might not have learned at any point in any case and I've checked out getting familiar with Weed.

Spotless, simple to explore the store. Costs are more than sensible, determination is really heavenly.

I'm glad to come here constantly!

Most delightful looking dispensary I've ever been to. Very efficient and showed, quite splendid, staff are cordial and supportive. The setup outside wasn't really awful (around a brief stand by), yet we went during the week.

I'd return!

This is the second legitimate pot shop in the City. The first is east along Sovereign close to College however this one is right in the centre of the biggest outside shopping region in Canada.

They request a picture ID at the entryway so be prepared with that. Then they inquire as to whether you need to be on their mailing list. I recommend not utilising a US based monster for email contacts because of security worries into what's in store. The store is very much staffed and had no issue staying aware of clients.

Orders are put and the salesman will give you a chit which is utilised at the checkout. Money would be the most ideal way to pay however they really do take all instalment choices.

Worth a look-see essentially for this page in Toronto and Canadian history.

I sincerely don't have the foggiest idea where to begin discussing what's going on with this spot. Anyway it's in good company in what's up with "lawful" government authorised dispensaries. Above all else there's the line up. How long has weed been legitimate you're letting me know that these puts still expect a line up as though it were a select club. It's really absurd to feel that the "non-lawful" spots were truly ready to sort this out and not have the requirement for these bogus lines only for appearances. So one success against Nova is the way that you need to stand by outside. I sat tight for 20 minutes in the outrageous intensity which then, at that point, transformed into downpour only for the honour of getting in. After getting in I actually needed to stand by.

As of now I understood my time was definitely worth the delivery cost and a couple of days hold on to have the option to arrange Precisely the same items from the lawful government site. This store is a joke and there are so many other predominant and better client care encounters accessible. It's simply a disgrace they're not lawful in light of the fact that that could undermine the syndication.

Lotus Toronto

Claims to fame

Same Day Weed Conveyance in the GTA - 24 hour Conveyance Expansive - Maryjane, Bloom, Edibles, Concentrates, Topicals, Shower Bombs and more!

History

Laid out in 2016.

Already working as York Dispensary at 1478 Eglinton West, we have now advanced into a one-stop online shop as Lotus Toronto! Protected, circumspect, speedy and solid assistance, directly to your entryway!

The Hunny Pot Co

Strengths

We are a freely claimed and worked marijuana retail organisation, and pleased to be Toronto's absolute first legitimate pot store, opening our lead area on Sovereign Road West April first, 2019. We invite you to our safe and delightfully planned stores, a spot for marijuana new-honey bees and specialists the same. At The Hunny Pot, you will track down the solutions to your consuming inquiries from our learned Budtenders, and the right weed items to accommodate your life. The Pot is brimming with your #1 pot strains from capable Authorised Makers across Canada; it's overflowing with tangible containers for your satisfaction, a well-organised pot menu to pick from, and an assortment of sweet pot extras.

History

Laid out in 2019.

Pleased to be Toronto's absolute first legitimate marijuana store, opening our entryways on April first, 2019.

Green Vendor Marijuana Shop

Site is not difficult to explore through and everything is very much itemised , they have a really broad choice including some "planner blossoms" like Cherry Punch, which is evaluated seriously.

Staff are incredibly amicable and will respond to anything that questions you have about their item, seems like they know a great deal better compared to most.

This is perfect for individuals who are simply getting into smoking and need educated ideas without being upsold

They Are at present doing control side get and furthermore offer same-day conveyance!

Quick help with extraordinary choice, I would suggest green traders over most different rivals nearby. The green dealer has additionally publicised parody occasions which assist stoners with getting out (however I have never gone). I desire to help this business in future :)

Superette

What a wonderful store! The marketing is fabulous, sort of retro 50's "soft drink stand". Enormous determination of product and exceptionally accommodating and well disposed staff. Great costs on numerous things as well!

I accept they recently opened and I intend to make a trip across town to give them my continuous business

The Hunny Pot

Claims to fame

The Hunny Pot impacted the world forever in Toronto on April 1, 2019, when it opened the primary lawful marijuana store in Ontario. The freely claimed and worked organisation has since extended its impression, setting up five additional areas to serve clients in Hamilton, Burlington, and Toronto. The Hunny Pot offers an organised menu including weed strains, oils and concentrates, pre-rolls, containers, edibles, and refreshments. All the organisation has made it its central goal to teach its clients about weed, keep a great stock of items and frills, and give an unparalleled client experience in its areas.

History

Laid out in 2019.

Glad to be Toronto's absolute first lawful weed store, opening our entryways on April first, 2019.

[localizee]

Our proprietary indoor cultivation techniques and our strain development are Higher than Most.

[sudeepkedar]

North America Cell Line Development Market to expand lucratively till 2027

North America Cell Line Development Market To Hit USD 2.9 Bn By 2027. North America cell line development market forecast will be strong on the back of developments in single-cell dispensaries, micro-robotics and flow cytometry. Notably, flow cytometry has gained uptick to boost efficiency during research activities. Cell lines are expected to be highly desirable in the growth of viral vaccines, biologics production and biopharmaceutical products.

Leading companies are expected to use cell lines in the production of monoclonal antibodies and recombinant proteins for cell culture and the identification of single-cell clones. Moreover, the prevalence of advanced technologies to produce cell lines, coupled with the development of regenerative medicine, will contribute to market growth.

Get sample copy of this research report @  https://www.graphicalresearch.com/request/1067/sample

Expanding penetration of bioreactors has stimulated growth potentials of cell line development equipment. Several cell line developments in drug screening and bioproduction will encourage companies to invest in the landscape. Besides, the use of robust storage equipment and single-use bioreactors will be pronounced over the next few years. North America cell line development industry share from equipment demand will grow at a healthy CAGR of 11% through 2027.

Mammalian cell line development could be dominant with surging demand from biopharmaceutical companies. It is worth noting that human embryonic kidney cells and the Chinese hamster ovary (CHO) are used in therapeutic protein production. Mammalian source captured over 71% share of North America cell line development market in 2020 and is expected to grow with the demand for research and biologics production.

The trend for cell line development will be apparent in drug discovery to assess the efficiency of drug toxicity and minimize cost and time during testing. Moreover, an upsurge in demand for new cancer treatment will expedite the need for cell line development. Drug discovery applications contributed around 11.8% share of North America cell line development industry in 2020.

Request for customization @

https://www.graphicalresearch.com/request/1067/customize-this-report

Hybridoma cell lines could be one of the fastest-growing segments due to wide application in the production of immunoglobin and monoclonal antibodies. It is worth noting that the technology has become highly desirable in the development of assay and research activities. North America cell line development market share from hybridoma segment is likely to grow at more than 10% CAGR up to 2027.

U.S. market will provide compelling growth opportunities on the heels of increasing healthcare budget, drug discoveries and technological advancements. Heightened awareness about monoclonal antibodies, along with the development of therapeutic drugs, will expedite the adoption of cell line development. For instance, demand for cell lines for vaccine production has surged exponentially for the treatment of smallpox and rotavirus. U.S. cell line development industry revenue is expected to observe around 11.4% CAGR through 2027.

Thermo Fisher Scientific, GE Healthcare, Sigma-Aldrich (Merck), Corning Inc., Vista Biologicals, Lonza Group, GVK BIO, Sartorius, Selexis SA and WuXi AppTec are some of the key players in cell line development market in North America. The competitiveness is such that these companies could focus on organic and inorganic strategies to gain a hold over the next few years.

About Graphical Research:

Graphical Research is a business research firm that provides industry insights, market forecast and strategic inputs through granular research reports and advisory services. We publish targeted research reports with an aim to address varied customer needs, from market penetration and entry strategies to portfolio management and strategic outlook. We understand that business requirements are unique: our syndicate reports are designed to ensure relevance for industry participants across the value chain. We also provide custom reports that are tailored to the exact needs of the customer, with dedicated analyst support across the purchase lifecycle.

 Contact US:

Parikhit B. Corporate sales, Graphical Research Email: sales@graphicalresearh.com Web: https://www.graphicalresearch.com/

[exadorlion]

identification - blue lions gang 

[mega-arushi-blog]

Oral Care Market 2025 Latest Technological Innovations Forecast

The global oral care market is segmented into product, distribution channel, and geography. The oral care market is segmented into toothpastes, toothbrushes & accessories, mouthwashes/rinses, denture products, dental accessories/ancillaries, dental prosthesis cleaning solutions and others, by product. Based on the distribution channel, the oral care market is classified as consumer stores, retail pharmacies, online distribution and dental dispensaries.

Get Sample Copy of this Report at - https://www.theinsightpartners.com/sample/TIPHE100000829/

Oral care have made progress in the last few years, harnessing technology for the supplement or increasing advanced technology. The newly toothbrushes are used independently or in concert with mobile apps for the optimization of user care and health outcomes. The report would be of an interest to various stakeholders operating in the oral care. These stakeholders include online distributions, consumer stores, medical manufactures and suppliers, academic & research institutes, medical care products manufacturers and vendors, distributors and others.

The objective of the study is to describe, define, and forecast the oral care market by product, distribution channel, and region. The report also provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and trends). The report helps to analyze market with respect to individual growth trends, prospects, and contributions to the overall oral care market.

The report analyzes factors affecting market from both demand and supply side and further evaluates oral care market dynamics effecting the oral care market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions. The report also includes the profiles of key manufacturing companies along with their SWOT analysis and market strategies.

The major players operating in the oral care market include Johnson & Johnson Services, Inc., Koninklijke Philips N.V, Lion Corporation, Procter & Gamble, Colgate-Palmolive Company, Church & Dwight Co., Inc., High Ridge Brands Co., Unilever, GlaxoSmithKline plc., and Sunstar Suisse S.A. among others. The company players are indulged into development of innovative products and programs to cater the demands of the users in oral care market. For instance, in January 2016, Lion Corporation launched a new and improved CLINICA ADVANTAGE toothpaste that contains the plaque-dispersing cleaning agent TDS, which makes plaque even easier to remove.

Purchase This Report at –https://www.theinsightpartners.com/buy/TIPHE100000829/

Reason to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the sleep apnea market.

-Highlights key business priorities in order to assist companies to realign their business strategies.

-The key findings and recommendations highlight crucial progressive industry trends in the global sleep apnea market, thereby allowing players across the value chain to develop effective long-term strategies.

-Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

-Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

-Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

About Us : The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

Contact Us: Call: +1-646-491-9876 Email: sales@theinsightpartners.com

[introvertwithaloudbrain-blog]

Lab 2: High Times

High Times magazine is very recognized as the ‘gold standard’ of weed publications. Founded in 1974 by smuggler and activist Thomas King Forcade, celebrating their 40th anniversary this year, it has been a enthusiastic advocate for the legalization of herb. According to its website, High Times has been the ‘preeminent source for cannabis information’ since its foundation. Forcade was a member of the Underground Press Syndicate, which was later known as the Alternative Press Syndicate. It was a group of counterculture newspapers developed in 1966. When he created High Times Magazine, it was initially meant as a joke. Forcade’s idea was to create a marijuana themed version of Playboy. At the start, urban legend claims that the publication was funded by drug money from the sale of weed. It was hard times for High Times in the beginning because support for legalized marijuana was at an all time low in the 1960s and 1970s. The herb was demonized and dismissed as the choice of lazy, unmotivated slackers. A Gallup Poll in October 2017 showed that support for legalized weed in America was at 64%. When High Times was founded, it was just 16%, which shows the uphill struggle the magazine has faced over the decades. High Times also has the "Cannabis Cup” which is the world’s foremost cannabis festival. Founded in 1988 by Steven Hager, the High Times Cannabis Cup is held each November in Amsterdam.  The High Times Cannabis Cup is the world’s leading marijuana trade show, celebrating the world of ganja through competitions, instructional seminars, expositions, celebrity appearances, concerts and product showcases. Hosted in states that have legalized medical and recreational marijuana, the Cannabis Cup stands as the foremost gathering place for the cannabis community to network and celebrate. Going strong for nearly three decades, High Times Cannabis Cups are the most established and trusted in the marijuana industry, continually fighting for the political legitimacy of the plant. The first issue was released on 1974, I’ll be analyzing the December 2018 issue. Study done in 2017 by New Theory claims the average recreational marijuana consumer is 37 years old. Marijuana dispensaries serve customers 21-95. The average marijuana consumer spends $33 on weed per trip to dispensary. Weed smokers spent $645 on average in the last year buying pot. There are more than twice as many men than women in the customer loyalty program. This makes the target market a large audience. Throughout the magazine all ads are of healthier ways of smoking and dispensary deals. From coupons for deals and new smoking devices cover the pages. They all relate to the theme of the magazine. If I were to publish a ad in this magazine I feel like it could go on any page because all the content of the magazine is the main theme marijuana. There might be just two ads that aren’t of deals or new devices for smoking. The total of ads are 56  and editorials 44, keeping a pretty good balance id say. As I read through the issue when ads came I didn’t lose interest in the page since it was all relevant to the articles. I would not consider myself the target demographic, since I wouldn’t purchase anything it advertises. But I would mind read through it and seeing what knowledge it offers. Gloria Steinem says “But, I also explained, I was thinking especially of women’s magazines. There, it isn’t just a little content that’s devoted to attracting ads, it’s almost all of it. That’s why advertisers-not readers-have always been the problem for Ms. As the only women’s magazine that didn’t supply what the ad world euphemistically de- scribes as “supportive editorial atmosphere” or “comple- mentary copy” (for instance, articles that praise food/ fashion/beauty subjects to “support” and “comple- ment” food/fashion/beauty ads), Ms. could never attract enough advertising to break even.” . In this magazine most ads are just the product alone, but all the ads are of the editorial topic. But I don’t agree with Steinem when she says that ads are the problem. I wouldn’t stop buying a product because of a bad ad or their need to over ad the magazine. The ads in this magazine motivate me to keep reading. Over all its a very simple target magazine that does its job perfectly, that has participated in the growing history of marijuana.

hightimes.com

[kiransable07]

Analysis of U.S. medical marijuana market applications and company’s active in the industry

A research study conducted by Global Market Insights, Inc., suggests that U.S. medical marijuana market is anticipated to cross $14.9 billion and depict a 10.5% growth rate through 2027. Strong prevalence of cancer is projected to give the U.S. medical marijuana market share an appreciable boost over the forecast spell. Chronic pain has become a major health issue among the U.S. population over the past years. In light of a current opioid epidemic, patients who are at high risks of chronic pain are also looking for alternative therapy for pain relief.

Request for a sample copy of this report @ https://www.gminsights.com/request-sample/detail/2890

With regards to the application spectrum, the pain management segment registered $5.5 billion of the U.S. medical marijuana industry revenue in 2020, as the pain condition is a prominent health issue among the regional population. According to the NHIS (National Health Interview Survey), over 25 million individuals in the United States suffer from pain per day. The segmental growth can further be credited to the exponential use of marijuana for pain management and other medicinal purposes.

In terms of segmentation by route of administration, the topical segment was valued at $374.6 million in 2020 and is poised to exhibit an 11.2% CAGR through 2027, due to the robust product demand for treating numerous skin related diseases like eczema and psoriasis, coupled with its mounting usage as an alternative to steroids.

Considering the distribution channel, the U.S. medical marijuana market from the dispensaries segment is expected to register remuneration worth $8.8 billion by 2027. This is a result of the accelerating number of legal dispensaries, alongside the rapid legalization of medical cannabis. Moreover, high prominence of pain-related diseases will also boost segmental expansion in years to come.

Despite the positive growth environments, the presence of strict regulations and quality standards may create challenges to the steady industry growth in the U.S.

The Pacific Central medical marijuana market is set to register a CAGR of 8.7% through 2027, which is attributable to the growing product applications as well as its legalization in major regions like California. The regional industry growth is further stimulated by the mounting number of patients and dispensaries in California. Rising shift towards adult-use cannabis since the legalization of the recreational use of the product may, however, impede regional market share to some extent in the foreseeable future.

The competitive landscape of the U.S. medical marijuana market consists of companies such as Aurora Cannabis, Inc., United Cannabis, Emerald Health Therapeutics, Tilray, GW Pharmaceuticals, Medical Marijuana, Inc., and Canopy Growth, among others. These companies are focusing on varied strategies like M&A and business expansions to consolidate their market position. To illustrate, in December 2020, Canada-based Tilray and Aphria announced plans to merge in an all-stock agreement to establish the largest cannabis company across the globe.

Browse key industry insights spread across 225 pages with 300 market data tables & 16 figures & charts from the report, “U.S. Medical Marijuana Market Size By Application (Pain Management, Muscle Spasms, Nausea, Anorexia, Seizures), By Route of Administration (Inhalation, Oral, Topical), By Distribution Channel (Dispensaries, Online), Industry Analysis Report, Zonal Outlook, Price Trends, Application Potential, Competitive Market Share & Forecast, 2021 - 2027” in detail along with the table of contents:

https://www.gminsights.com/industry-analysis/us-medical-marijuana-market



About Global Market Insights:

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:

Arun Hegde

Corporate Sales, USA

Global Market Insights, Inc.

Phone:1-302-846-7766

Toll Free: 1-888-689-0688

Email: sales@gminsights.com

Web: https://www.gminsights.com/

[gaytigres]

Weed Online – An Overview

Decriminalizing and regulating marijuana would reduce the access of minors to opioids and other, more complicated substances. Teenagers have found it easier to get their hands-on marijuana for years, than possessing a bottle of alcohol is for them. And that's basically because alcohol is limited, readily available, and therefore not lucrative for sale to your local drug dealer. However, marijuana is profitable and a great Segway for the dealer to push the teen, probably impressive, into something harder, more addictive and very profitable for him. You can learn more at dispensary near me.

Another argument, while we're on the topic of legislation, is that in this case the dealer could be selling something dangerous like synthetic marijuana, or even marijuana laced with alcohol, and the customer, possibly someone in need of relief from an ailment, could be none-the-wiser and do a lot of harm to their health.

Billions of dollars in marijuana sales help power drug syndicates and disappear from the US economy. You could use that money to generate a huge amount of tax revenue. In reality, Colorado has raised more than $12 million in taxes as of March, in just three months of legalization. That money, pre-regulation would have gone directly into the hands of drug lords, and would probably have been used to finance their hard narcotics trade. And this is only one condition, a microcosm of the looming potential. There are a slew of new cannabis-related businesses that have gone public, and whose stocks are traded as the infamous "marijuana stocks," just another stimulus for the local economy.

Marijuana. Marijuana. Enough to tell. Okay, not necessarily but it should be-let me fill you in on the awesome by-product of the cannabis plant that we offer. Not only does hemp give us mankind's greatest natural fibre, it also gives us construction material, plastic , paper, and you can even eat the stuff!

George Washington grew marijuana, he was fascinated by its therapeutic potential as documented in his diary, but it was hemp that appealed even greater. He even made it mandatory, at one stage, for farmers to grow the plant. And it turns out he was on something: now hemp stalks are being turned into bio-fuel. This can go a long way in itself in reducing carbon emissions.

[liveindiatimes]

Delhi Civic Body Headquarters Sealed After 3 Employees Test COVID-19+ve

https://liveindiatimes.com/delhi-civic-body-headquarters-sealed-after-3-employees-test-covid-19ve/

A disinfection drive will be carried out for next 48 hours, said an official. (Representational)

New Delhi:

The New Delhi Municipal Council (NDMC) sealed its headquarters in central Delhi on Thursday after three employees tested positive for COVID-19, taking the total number of infected staffers to nine.

“A Joint Director level employee has been found positive for COVID-19. Two more tested positive today. Contact tracing is being done by district authorities as per protocol. The building has been sealed. A disinfection drive will be carried out for next 48 hours,” a senior NDMC official said.

“Meanwhile, all employees will be working from home till the building is completely sanitised and reopened. The employees who came in contact with those infected have been advised to observe home quarantine and report to district authorities in case they become symptomatic,” the official added.

Three employees of the NDMC had tested positive for COVID-19 on Wednesday, prompting the civic body to seal a floor of its headquarters in Lutyens’ Delhi and a section of another building housing its office in Gole Market.

Earlier three employees of the NDMC, including a sanitation worker and engineer, had tested positive for COVID-19.

Last week, a doctor at an NDMC dispensary had tested positive for COVID-19, following which the premises of the health facility was sealed.

(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)

Live India Times

[industryjournals]

Medical Marijuana market Application, New Trends Till 2026

The detailed market intelligence report on the Medical Marijuana market applies the best of both primary and secondary research to weighs upon the competitive landscape and the prominent market players expected to dominate the Medical Marijuana market for the forecast period, 2019 - 2026. The study not only scans through the company profile of the major vendors but also analyses their winning strategies to give business owners, stakeholders and field marketing personnel a competitive edge over others operating in the same space. A detailed evaluation of the major events such as acquisition and mergers, collaborations, product launches, new entrants, and technology advancements offer a complete overview of what the future of the Medical Marijuana market will be like in the years to come.

Request For Free PDF Sample Of This Research Report At: https://www.reportsanddata.com/sample-enquiry-form/1413

Market Size – USD 11.70 Billion in 2018, Market Growth - CAGR of 26.4%, Market Trends – Legalization of marijuana in several countries.

Key participants include Canopy Growth Corporation, Aphria, Inc., Aurora Cannabis, Maricann Group, Inc., Tilray, Cronos Group, Organigram Holdings, Inc., Vivo Cannabis, Tikun Olam, Insys Therapeutics, Inc., MedReleaf Corporation, and GW Pharmaceuticals PLC.

Scope of the Report:

Based on the in-depth analysis the research also brings to light major facts pertaining to the vital aspects such as market share, size, and growth rate. Deep dive into other aspects including the investment feasibility, demand and supply, import and export status, supply chain management and growth prospects narrates a lot about what the business environment will be like for the forecast period,2019 - 2026. All the vital statistics in the report are explained with the help of resources such as tables, charts, and info graphics.

Various research techniques are applied to produce data on competitors’ strategies; past, present and future sales and purchasing trends. Business owners aiming to inspect the present consumer base and reaching the target audience will be able to leverage the demographic details derived from different regions, to infer dynamic market shifts. Perspectives on different disruptive forces that are believed to have a transformative influence on the future sales make the document valuable. Insights on where the Medical Marijuana market should be heading during the forecast years from 2019 to 2026. The report also sheds light on how major vendors are transforming the business today.

Segments covered in the report:

For the purpose of this report, Reports and Data have segmented the global Medical Marijuana Market on the basis of Product Type, Route of Administration, Distribution Channel, Medical Application, and Region:

Product Type Outlook (Revenue, USD Billion; 2016-2026)

Oil

Buds

Tinctures

Medical Application Outlook (Revenue, USD Billion; 2016-2026)

Chronic Pain

Mental Disorders

Anorexia

Seizures

Muscle Spasm

Cancer

Others

View Exhaustive Market Research Press Release@ https://www.reportsanddata.com/press-release/global-medical-marijuana-market

Route of Administration Outlook (Revenue, USD Billion; 2016-2026)

Inhalation

Oral

Intravenous

Topical

Distribution Channel Outlook (Revenue, USD Billion; 2016-2026)

Dispensaries

Online

Regional Outlook (Revenue, USD Billion; 2016-2026)

North America

Europe

Asia-Pacific

Latin America

The study predicts what the future Medical Marijuana market can be expected to witness. The research also familiarizes product owners with immediate threats in the market, buyer’s requirements, and the effective business strategies implemented by prominent industry players. The report aims to help both existing companies and new entrants not only prepare against the disruption but also see opportunities. In-depth examination of market trends, including the assessment of government bodies, financial organization, and other regulatory bodies. Starting with a macroeconomic outlook, the study performs a detailed examination of the sub-categories of the industry and the trends that have an impact on the business.

Browse the comprehensive TOC and data tables @ https://www.reportsanddata.com/report-detail/medical-marijuana-market

The research provides answers to the following key questions: 

What will be the marketing and pricing strategies adopted by prominent vendors operating in the Medical Marijuana market for the forecast years from 2019 to 2026?

What are the new uses for the existing products or services and how have they contributed towards increasing the demand for products or services?

What are the general conditions prevailing and influencing the business environment of the Medical Marijuana market?

Who are the key manufacturers venturing into new geographies to establish a lucrative market their products and services?

What will be the dynamics of the demand and supply and the requirements of the distribution channel across the globe in the near future?

What will be the market share of the Medical Marijuana industry over the considered time periods?

About Us: Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Contact Us: John Watson Head of Business Development Direct Line: +1-212-710-1370 E-mail: sales@reportsanddata.com Reports and Data | Web: www.reportsanddata.com

[hempindustry-blog]

Texas Weed Syndicate started its life as a Legal Dispensary Finder and is now Expanding to be a dispensary / cbd store / smoke shop finder. They also operate their own CBD shop online where all types of CBD products including premium hemp flower are sold! The product offerings also include pain creams, gummies, tinctures and […]

[healthcare00897]

Medical Cannabis Market Growth and Demand Analysis By Global Top Key Players Like and Others 2018-2026

Medicinal cannabis, also known as medical marijuana, is used either for the treatment of diseases or to improve their symptoms. The two cannabinoids - delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) are used in treatment of certain diseases or health conditions such as pain, blood pressure, memory, concentration, appetite, sensory stimulus, muscular problems, and seizures. Marijuana was the most widely used drug globally in 2014 with around 183 million users.

Download PDF Brochure Of This Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/40

Such factors have led to increasing initiatives among governments worldwide to conduct studies regarding legalization of the drug for medicinal use. The U.S National Institute on Drug Abuse is conducting research on cannabis (marijuana) to treat numerous diseases and conditions such as autoimmune diseases, pain, inflammation, seizures, mental disorders, and substance abuse disorders. Regulatory compliance is a key factor that influences cost, quality, and safety of cannabis (marijuana) as well as the capacity for the manufacturers in the medicinal cannabis market to be responsive, scalable, and innovative.

The global medicinal cannabis market is estimated at US$ 5,448.4 million in 2019 and is expected to witness a CAGR of 24.4% over the forecast period (2019 – 2027).

Increase In The Legalization Of Medicinal Cannabis In Various Economies Is Expected To Augment The Market Growth

Increasing approvals for medicinal cannabis products and growing research and development activities in the medicinal cannabis market are expected to support growth of the market. For instance, in March 2017, Germany’s parliament passed a law allowing medicinal use of the cannabis plant by allowing healthcare professionals to prescribe medicinal cannabis products to patients suffering from health issues such as chronic pain, vomiting, and nausea. However, health issues resulting from excessive cannabis consumption such as tachycardia, risk of heart attack, particularly in individuals with existing heart disease or arrhythmias, are expected to restrain growth of the market.

Legalization of medicinal cannabis is expected to grow once conclusive evidence regarding its safety and efficacy is obtained through extensive research. For instance, in 2013, Czech Republic legalized medicinal marijuana for patients suffering from chronic pain, epilepsy, chemotherapy induced side effects, and other severe disease indications. Furthermore, the law allows patients with marijuana prescription to purchase medicinal marijuana from pharmacies. However, cultivation of marijuana in not allowed in the country, and thereby suppliers need to import medicinal cannabis. These factors are expected to contribute to the growth of the medicinal cannabis use in pharmaceutical and biotechnology industry.

Medicinal Cannabis Market - Regional Insights

On the basis of region, the global medicinal cannabis market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

North America is expected to hold dominant position in the global medicinal cannabis market during the forecast period manufacturers U.S. medical cannabis market are focusing on expansion strategies to increase their product portfolio. For instance, in July 2016, Insys Therapeutics, Inc. received the U.S. Food and Drug Administration (FDA) approval for dronabinol oral solution, Syndros, an orally administered liquid formulation of the pharmaceutical, cannabinoid dronabinol. Syndros is indicated in treatment of anorexia associated with weight loss among patients suffering from AIDS and those suffering from cancer chemotherapy-induced nausea and vomiting.

Potential medicinal cannabis markets other than the U.S. include Canada, Israel, Australia, and Spain. Mexico is also in process of legalizing cannabis. For instance, in February 2016, Medical Marijuana, Inc. launched the HempMeds Mexico, a CBD hemp oil product, in Mexico. With the launch of HempMeds Mexico, the company intends to expand its cannabis business in Latin America by establishing labs, manufacturing facilities, and sales and distribution facilities in the region in the near future.

Inquire Here Before Purchase of Research Report @ https://www.coherentmarketinsights.com/insight/talk-to-analyst/40

Medicinal Cannabis Market - Competitive Landscape

Some of the key players operating in medicinal cannabis market include BOL Pharma, Tilray, Medreleaf Corporation, Aurora Cannabis, Inc., Canopy Growth Corporation, Insys Therapeutics, Inc., Aphria, Inc., MGC Pharmaceuticals Limited, GW Pharmaceuticals, plc., and Medical Marijuana Inc.

Detailed Segmentation:

   Global Medicinal Cannabis Market, By Point of Sale:

       Dispensaries

       Online Pharmacy

       Hospital Pharmacy

   Global Medicinal Cannabis Market, By Active Ingredient:

      Tetrahydrocannabinol (THC)

       Cannabidiol (CBD)

   Global Medicinal Cannabis Market, By Therapeutic Application:

       Pain

       Arthritis

       Neurological Disease

           Epilepsy

           Multiple Sclerosis

           Other Neurological Applications

       Other Applications

   Global Medicinal Cannabis Market, By Geography:

       North America

Europe

Asia Pacific

Latin America

Middle East

Africa

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us

Mr. Shah

Coherent Market Insights

1001 4th Ave, #3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

[friendeel9-blog]

Dr. Lloyd's Sanitarium - 6-8 St. Nicholas Place

In 1884 John Fink commissioned architect Richard S. Rosenstock to design a commodious suburban home in the area that would later be dubbed Sugar Hill.  The principal in the pork packing firm of John Fink & Son, his new residence would reflect his significant personal wealth. Rosenstock designed a three-story, freestanding residence in the trendy Queen Anne Style.  Although his plans called for a "brown stone front dwelling," only the basement and first floor were faced in rough cut stone.  The second floor was clad in brick and the top floor in wood.  True to the Queen Anne style, the house featured a riot of angles, shapes, and colors.  Dormers poked through the fanciful jerkinhead gables, and a corner tower clung to the two upper floors.  A profusion of stained glass and scattered carvings delighted the eye.  The cost of construction would be equal to about $924,000 today.

Carved portrait keystones and stained glass transoms survive at the northern corner.

Located at No. 8 St. Nicholas Place, on the northeast corner of 150th Street, Fink's stylish home and its bucolic hilltop location may have been a deciding factor in James A. Bailey's decision to built his imposing mansion on across the street, at No. 10.  The Real Estate Record & Builders' Guide, on January 16, 1896, commented "One of handsomest residences on this avenue is that of John W. Fink, son of Commissioner Fink of railroad fame.  It is situated o the northeast corner of One Hundred and Fiftieth street, and is a three-story ornate stone front building, having all the modern improvements."

The original entrance porch with its sideways stoop is evident in this early photo, as is the wonderful turret.  Directly behind is the James A. Bailey house.  from the collection of the Museum of the City of New York 

An avid boater, Fink was active among the wealthy sportsmen of northern Manhattan.  On May 29, 1888, for instance, The Evening World commented, "John W. Fink, of the Friendship Boat Club, is said to be the probable winner of the junior singles of the Harlem River regatta."

The construction date is worked into the elaborate carving on the first floor chimney back.

A delightful detail is Stein's continuing the gable level over the chambered rear corner.

That same year Fink sold the house, along with the vacant property extending east to Edgecomb Avenue, to real estate operator Charles E. Runk and his wife, Aurelia.  Runk was also the treasurer of the Washington Heights Taxpayers' Association, and a partner in the Oneota Fertilizer and Chemical Co. The Runks' ownership would be short-lived.  On March 9, 1891 they sold No. 8 to Sigmund Bergmann for $31,750, just over $900,000 today.  Bergmann was a partner with Edward H. Johnson and Thomas Alva Edison in the Bergmann Electric & Gas Fixture Co.

Sigmund Bergmann was a partner with inventor Thomas A. Edison.  Electrical Review and Western Electrician, December 21, 1912 (copyright expired)

Bergmann had left his native Germany in 1870 at the age of 21, already trained as an engineer.  The Electrical Review and Western Electrician later explained "He was associated with Edison for several years and being imbued with the idea that he should turn his talents in a direction that would insure to him the greatest possible personal reward he established a business of his own."  That move did not injure his friendship with Edison nor their businesses connections.  His lifelong friend, Francis Jehl, later said "many of Edison's experiments were made in the Bergmann shop, while the phonograph was to a great extent developed with Bergmann's assistance." In 1893 Charles Runk sold the undeveloped eastern plot and at the same time removed the restrictive covenants John Fink had originally built into the deeds.  It was a move that would have serious impact on No. 8 a few decades later. Simultaneously Jacob P. Baiter and his wife, Kate, began construction on their upscale residence next door at No. 6.  Their architect, Theodore G. Stein, file plans on May 26 for a 25-foot wide, four story brick dwelling to cost $35,000 (or about $1 million today).  Completed the following year, it could not have been more different than its neighbor.

Stein had turned to the more formal Renaissance Revival style with undeniable Romanesque Revival influences.  He embellished the beige brick with terra cotta decorations and included a rounded bay at the second floor.  The top floor took the form of a steep mansard, its gabled dormer ornamented with an intricate panel of tangled bows, wreaths and swags. Jacob Baiter was the East Coast manager of the Fleischmann Yeast Company, and so it is most likely not a coincidence that Max Fleischmann would soon live almost directly across the street at No. 400 West 149th Street.  Yeast was an important part in the making of alcohol, and both men were involved, as well, in the Ridgewood Distillery, the Eastern Distilling Co., and the Somerset Distilling Co.

Originally a high sideways stoop led to the doorway.

Jacob and Kate had two sons, Charles William Grevell and Louis J. Baiter.  Kate Baiter died in the house on October 26, 1898.  Her funeral was held here three days later. Jacob's grief was rather short lived.  The following year he married and transferred title to No. 6 to his new wife, Carrie.  The Evening Post Record of Real Estate Sales listed the transaction as "gift." In 1909, the same year that Charles Baiter was married, Dr. Henry William Lloyd purchased No. 8.  Charles Runk's removal of the deed restrictions allowed Lloyd to convert the house to The Audubon Sanitarium.  Having a private hospital next door may have been too much for the Baiters, and in October 1911 they sold their home to Dr. Lloyd for $75,000.  The Sun reported that he "will use it for his own occupancy." And, indeed, he did--for a few months.  In 1912 he joined the two structures with a somewhat ungainly addition.  A new entrance was established within the new portion.

In 1942 the former Baiter house still retained its stoop.  via the Office for Metropolitan History

Things inside the upscale sanitarium did not always go smoothly, sometimes resulting in unwanted publicity.  On March 18, 1912, for instance, The Sun reported on the investigation by Coroner Holzhauser and the police into "the death of Miss Alice Anderson in the sanitarium of Dr. Henry W. Lloyd at 8 St. Nicholas place early yesterday morning." The article carefully tip-toed around the fact that Alice, who was 30-years-old, had come for an abortion.  According to Dr. Lloyd, she had already received a botched procedure and that he told her "that she probably would not survive the second operation."  So certain was he that his patient would die, before starting the procedure he sent for a priest to hear her confession.  Before she died she "told her three sisters who was responsible for her condition," said The Sun. Five months later a journalist from The Sun was back, this time at the request of Mrs. Sarah Harris.  The 34-year-old, referred to as "the sufferer" by the newspaper, had been stricken with a "strange malady" three years earlier which paralyzed her from the neck down.  Able to move only her head, she had lain in the same position the entire time. On August 31, 1912 the newspaper entitled its article "Woman Paralytic Begs State To End Her Life."  In it Sarah pleaded "We have our Societies for the Prevention of Cruelty to Animals, which put out of their agony injured and sick animals, but human beings for whom medicine can do nothing are kept on in their torture.  Why should this be?" Mrs. Harris did not get her wish and in 1915, when Dr. Lloyd hired architect George H. Hardway to enlarge the sanitarium, she was still a patient.  The addition housed a "new maternity hospital," as described by The New York Times.

Close inspection reveals a winged, terra cotta rampant lion atop the gable.  The stylized sunflower on the metal facing below is a familiar Queen Anne motif.

Dr. Lloyd's Audubon Sanitarium saw celebrated figures come and go.  In 1917 the wife of preacher Billy Sunday received an emergency appendectomy.  The operation removed a "strangulated tumor" as well.  On May 20 The New York Times noted "Though deeply distressed by his wife's illness, Billy Sunday preached last night to 22,000 persons." The same operation was performed on Lucien Muratore, principal tenor of the Chicago Opera Company in February 1922.  Newspapers carried updates on his condition for days. Dr. Henry W. Lloyd sold the properties in January 1925 to the Louis H. Low Syndicate.  There were 100 rooms in the complex at the time.  The new owners, according to The Times on January 24, had already leased it to the newly-formed Lloyd's Sanitarium, Inc. (headed by Dr. Victor Low) "who will continue the operation of same after extensive alterations and improvements."  Architect Henry F. Schlumbohn, Jr. was called upon to update the hospital and dispensary. By 1935 the name had been changed to The Community Hospital.  The admission fee was 35 cents and a "revisit fee" was a quarter. The clinic was gone by mid-century, when the mish-mash of buildings was operated as a 53-room hotel.  As the neighborhood declined, so did the the property and by 1983 it was run by the city's welfare program as the Dawn Hotel, "housing formerly homeless families," according to The New York Times on August 25 that year.

The Dawn Hotel sat within what had become a gritty neighborhood.  Late on the night of December 6 a man entered the lobby and got into an argument with the clerk.  At around 1:00 on the morning he returned, armed with a pistol  and, according to police, "shot the clerk in the chest and fled from the hotel."  

As the Sugar Hill neighborhood improved in the 21st century, the Dawn Hotel did not.  A New York Senate report in January 2017 on the State's "unclean, unsafe, dangerous temporary shelter system" awarded the Dawn Hotel the uncomplimentary title of No. 1 in the top ten hotel violators in the state.  The facility was closed by 2018.

The once handsome houses have been sorely abused throughout their various connected uses.  And yet glimpses of their former splendor still manage to seep through. photographs by the author

Source: http://daytoninmanhattan.blogspot.com/2019/07/dr-lloyds-sanitarium-6-8-st-nicholas.html